Published in JAMA on July 19, 2000
Patient-reported outcomes of breast reconstruction after mastectomy: a systematic review. J Am Coll Surg (2009) 1.94
Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer. Mayo Clin Proc (2010) 1.51
The role of prophylactic surgery in cancer prevention. World J Surg (2007) 1.51
Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors. Breast Cancer Res Treat (2006) 1.20
The psychosocial impact of bilateral prophylactic mastectomy: prospective study using questionnaires and semistructured interviews. BMJ (2001) 1.11
Expression of cancer testis antigens in human BRCA-associated breast cancers: potential targets for immunoprevention? Cancer Immunol Immunother (2011) 1.08
Determining whether a patient is feeling better: pitfalls from the science of human perception. J Gen Intern Med (2011) 0.98
Genetic risk assessments in individuals at high risk for inherited breast cancer in the breast oncology care setting. Cancer Control (2012) 0.93
Role of Breast Surgery in BRCA Mutation Carriers. Breast Care (Basel) (2012) 0.91
Challenging and complex decisions in the management of the BRCA mutation carrier. J Womens Health (Larchmt) (2013) 0.89
Support needs and acceptability of psychological and peer consultation: attitudes of 108 women who had undergone or were considering prophylactic mastectomy. Psychooncology (2008) 0.89
Body image issues after bilateral prophylactic mastectomy with breast reconstruction in healthy women at risk for hereditary breast cancer. Fam Cancer (2013) 0.89
Looking different, feeling different: women's reactions to risk-reducing breast and ovarian surgery. Fam Cancer (2012) 0.88
Personalized medicine: the future is not what it used to be. Surgery (2009) 0.87
Acceptance of preventive surgeries by Israeli women who had undergone BRCA testing. Fam Cancer (2006) 0.85
United States trends in the surgical treatment of primary breast cancer. World J Surg (2012) 0.83
Long-term satisfaction and quality of life following risk reducing surgery in BRCA1/2 mutation carriers. Hered Cancer Clin Pract (2014) 0.80
Can self-esteem, mastery and perceived stigma predict long-term adjustment in women carrying a BRCA1/2-mutation? Evidence from a multi-center study. Fam Cancer (2010) 0.78
Decision Regret following Treatment for Localized Breast Cancer: Is Regret Stable Over Time? Med Decis Making (2014) 0.78
Quality of life among patients after bilateral prophylactic mastectomy: a systematic review of patient-reported outcomes. Qual Life Res (2015) 0.78
Management of the asymptomatic BRCA mutation carrier. Appl Clin Genet (2010) 0.78
Contralateral Prophylactic Mastectomy (CPM) Consensus Statement from the American Society of Breast Surgeons: Data on CPM Outcomes and Risks. Ann Surg Oncol (2016) 0.77
Prophylactic and Therapeutic Breast Conservation in BRCA1/2 Mutation Carriers. Int J Breast Cancer (2011) 0.77
Standard psychological consultations and follow up for women at increased risk of hereditary breast cancer considering prophylactic mastectomy. Hered Cancer Clin Pract (2009) 0.77
Patient Satisfaction and Quality of Life in DIEAP Flap versus Implant Breast Reconstruction. Surg Res Pract (2015) 0.77
Long-term outcomes of risk-reducing surgery in unaffected women at increased familial risk of breast and/or ovarian cancer. Fam Cancer (2015) 0.76
Breast cancer. BMJ (2002) 0.76
A model for individualized risk prediction of contralateral breast cancer. Breast Cancer Res Treat (2016) 0.75
Innovative practice model to optimize resource utilization and improve access to care for high-risk and BRCA+ patients. Can J Surg (2017) 0.75
Contralateral prophylactic mastectomy: current perspectives. Int J Womens Health (2016) 0.75
Comparison of satisfactions from mastectomy and Lump Ectome in breast cancer patients. J Educ Health Promot (2014) 0.75
Decision making for breast cancer prevention among women at elevated risk. Breast Cancer Res (2017) 0.75
Commentary: Bilateral risk-reducing mastectomy is the safest strategy in BRCA1 carriers. Front Psychol (2017) 0.75
Breast and ovarian cancer risk management in a French cohort of 158 women carrying a BRCA1 or BRCA2 germline mutation: patient choices and outcome. Fam Cancer (2012) 0.75
New names for old disciplines. J Inherit Metab Dis (2002) 0.75
Risk of connective-tissue diseases and other disorders after breast implantation. N Engl J Med (1994) 9.25
A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration. N Engl J Med (1997) 8.43
Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med (1999) 7.81
Information needs and decisional preferences in women with breast cancer. JAMA (1997) 7.46
Decision making during serious illness: what role do patients really want to play? J Clin Epidemiol (1992) 6.66
The Control Preferences Scale. Can J Nurs Res (1997) 6.28
Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum Hered (2003) 5.06
Glomerular filtration rate estimated by cystatin C among different clinical presentations. Kidney Int (2006) 4.59
Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet (2000) 4.43
Associations of general and abdominal obesity with multiple health outcomes in older women: the Iowa Women's Health Study. Arch Intern Med (2000) 4.36
Evaluation of candidate genes in case-control studies: a statistical method to account for related subjects. Am J Hum Genet (2001) 4.09
Molecular characterization of the Clostridium difficile toxin A gene. Infect Immun (1990) 4.06
Differential characteristics of catalase-positive campylobacters correlated with DNA homology groups. Can J Microbiol (1984) 3.93
Carbohydrates, dietary fiber, and incident type 2 diabetes in older women. Am J Clin Nutr (2000) 3.93
Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA (1995) 3.84
Deoxyribonucleic acid homology in bacterial taxonomy: effect of incubation temperature on reaction specificity. J Bacteriol (1968) 3.74
Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine. J Intern Med (2011) 3.63
Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol (2000) 3.61
Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers. J Natl Cancer Inst (1999) 3.46
Cell wall composition and deoxyribonucleic acid similarities among the anaerobic coryneforms, classical propionibacteria, and strains of Arachnia propionica. J Bacteriol (1972) 3.43
Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst (2001) 3.37
Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer Res (1998) 3.36
Sporadic medulloblastomas contain PTCH mutations. Cancer Res (1997) 3.22
Incidence of reading disability in a population-based birth cohort, 1976-1982, Rochester, Minn. Mayo Clin Proc (2001) 3.18
Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer. JAMA (2000) 3.15
Nucleotide sequence of Clostridium difficile toxin B gene. Nucleic Acids Res (1990) 2.93
PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. J Natl Cancer Inst (2001) 2.90
Effect of age and gender on sudomotor and cardiovagal function and blood pressure response to tilt in normal subjects. Muscle Nerve (1997) 2.86
Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes Control (2000) 2.85
Physical fitness as a predictor of cardiovascular mortality in asymptomatic North American men. The Lipid Research Clinics Mortality Follow-up Study. N Engl J Med (1988) 2.84
The pterin molybdenum cofactors. J Biol Chem (1992) 2.74
Body fat distribution and 5-year risk of death in older women. JAMA (1993) 2.70
Cognitive impairment after ECT in patients with Parkinson's disease and psychiatric illness. Am J Psychiatry (1992) 2.68
The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas. Am J Hum Genet (2001) 2.68
Religious involvement, spirituality, and medicine: implications for clinical practice. Mayo Clin Proc (2001) 2.66
Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990. Neurology (1999) 2.62
Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai Breast Cancer Study. Int J Cancer (2000) 2.62
Postural tachycardia syndrome (POTS). Neurology (1995) 2.59
Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism. Br J Psychiatry (1999) 2.55
Characterization of the molybdenum cofactor of sulfite oxidase, xanthine, oxidase, and nitrate reductase. Identification of a pteridine as a structural component. J Biol Chem (1980) 2.51
Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many kinds of breast cancer are there? Cancer Epidemiol Biomarkers Prev (1995) 2.50
Diet and risk of non-Hodgkin lymphoma in older women. JAMA (1996) 2.46
Physical activity and mortality in postmenopausal women. JAMA (1997) 2.45
Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis. J Exp Med (2001) 2.41
Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest (1998) 2.37
Relation of calcium, vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women. Am J Epidemiol (1999) 2.36
Linkage analysis with multiplexed short tandem repeat polymorphisms using infrared fluorescence and M13 tailed primers. Genomics (1995) 2.36
Nucleic acid homologies among oxidase-negative Moraxella species. J Bacteriol (1970) 2.35
Sugar, meat, and fat intake, and non-dietary risk factors for colon cancer incidence in Iowa women (United States). Cancer Causes Control (1994) 2.33
Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda. AIDS (2000) 2.32
Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study. Neurology (2000) 2.31
Bidirectional effects of cytokines on the growth of Mycobacterium avium within human monocytes. J Immunol (1991) 2.29
Neuropsychiatric correlates and treatment of lenticulostriatal diseases: a review of the literature and overview of research opportunities in Huntington's, Wilson's, and Fahr's diseases. A report of the ANPA Committee on Research. American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci (1998) 2.28
Dietary assessment of older Iowa women with a food frequency questionnaire: nutrient intake, reproducibility, and comparison with 24-hour dietary recall interviews. Am J Epidemiol (1992) 2.28
Major histocompatibility complex class II alleles and the course and outcome of MS: a population-based study. Neurology (1998) 2.26
Structural and metabolic relationship between the molybdenum cofactor and urothione. Proc Natl Acad Sci U S A (1982) 2.26
Taxonomy of the Clostridia: ribosomal ribonucleic acid homologies among the species. J Gen Microbiol (1975) 2.25
Incremental costs of enrolling cancer patients in clinical trials: a population-based study. J Natl Cancer Inst (1999) 2.25
Determining incidence of extended spectrum beta-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001-2002. Int J Antimicrob Agents (2004) 2.21
ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT (2001) 2.21
Genetic analysis of mammographic breast density in adult women: evidence of a gene effect. J Natl Cancer Inst (1997) 2.21
Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study. Mov Disord (2000) 2.20
Potential influence of migration bias in birth cohort studies. Mayo Clin Proc (1998) 2.19
Treatment decision making in women newly diagnosed with breast cancer. Cancer Nurs (1996) 2.17
Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer. Oncogene (2001) 2.17
Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804. Ann Oncol (2007) 2.17
Defining prostate specific antigen progression after radical prostatectomy: what is the most appropriate cut point? J Urol (2001) 2.15
Serpulina pilosicoli sp. nov., the agent of porcine intestinal spirochetosis. Int J Syst Bacteriol (1996) 2.14
Case-control studies of genetic markers: power and sample size approximations for Armitage's test for trend. Hum Hered (2001) 2.14
Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group Trial. J Clin Oncol (2000) 2.11
Better breast cancer survival for postmenopausal women who are less overweight and eat less fat. The Iowa Women's Health Study. Cancer (1995) 2.09
Human epithelial ovarian cancer allelotype. Cancer Res (1993) 2.08
Mortality and cancer rates in nonrespondents to a prospective study of older women: 5-year follow-up. Am J Epidemiol (1994) 2.06
On appetite and its loss. J Clin Oncol (2000) 2.06
Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. J Infect Dis (1999) 2.06
Paradoxical reactions in HIV and pulmonary TB. Chest (1998) 2.05
Complications leading to surgery after breast implantation. N Engl J Med (1997) 2.05
Lung cancer risk reduction after smoking cessation: observations from a prospective cohort of women. J Clin Oncol (2003) 1.99
The pterin component of the molybdenum cofactor. Structural characterization of two fluorescent derivatives. J Biol Chem (1984) 1.99
Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study. JAMA (1999) 1.96
Increased risk for cancer in patients with the Peutz-Jeghers syndrome. Ann Intern Med (1998) 1.96